ACAD
Price
$25.99
Change
-$0.24 (-0.91%)
Updated
Aug 29 closing price
Capitalization
4.38B
73 days until earnings call
AURA
Price
$6.26
Change
-$0.17 (-2.64%)
Updated
Aug 29 closing price
Capitalization
388.87M
68 days until earnings call
Interact to see
Advertisement

ACAD vs AURA

Header iconACAD vs AURA Comparison
Open Charts ACAD vs AURABanner chart's image
ACADIA Pharmaceuticals
Price$25.99
Change-$0.24 (-0.91%)
Volume$1.32M
Capitalization4.38B
Aura Biosciences
Price$6.26
Change-$0.17 (-2.64%)
Volume$130.56K
Capitalization388.87M
ACAD vs AURA Comparison Chart in %
Loading...
ACAD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
AURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACAD vs. AURA commentary
Aug 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACAD is a StrongBuy and AURA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 30, 2025
Stock price -- (ACAD: $25.99 vs. AURA: $6.26)
Brand notoriety: ACAD and AURA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACAD: 67% vs. AURA: 74%
Market capitalization -- ACAD: $4.38B vs. AURA: $388.87M
ACAD [@Biotechnology] is valued at $4.38B. AURA’s [@Biotechnology] market capitalization is $388.87M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.25B to $0. The average market capitalization across the [@Biotechnology] industry is $1.85B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACAD’s FA Score shows that 1 FA rating(s) are green whileAURA’s FA Score has 1 green FA rating(s).

  • ACAD’s FA Score: 1 green, 4 red.
  • AURA’s FA Score: 1 green, 4 red.
According to our system of comparison, ACAD is a better buy in the long-term than AURA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACAD’s TA Score shows that 3 TA indicator(s) are bullish while AURA’s TA Score has 2 bullish TA indicator(s).

  • ACAD’s TA Score: 3 bullish, 4 bearish.
  • AURA’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, ACAD is a better buy in the short-term than AURA.

Price Growth

ACAD (@Biotechnology) experienced а +0.97% price change this week, while AURA (@Biotechnology) price change was -4.43% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.70%. For the same industry, the average monthly price growth was +20.57%, and the average quarterly price growth was +29.45%.

Reported Earning Dates

ACAD is expected to report earnings on Nov 11, 2025.

AURA is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (-0.70% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ACAD($4.39B) has a higher market cap than AURA($389M). ACAD YTD gains are higher at: 41.635 vs. AURA (-23.844). ACAD has higher annual earnings (EBITDA): 104M vs. AURA (-107.51M). ACAD has more cash in the bank: 762M vs. AURA (177M). AURA has less debt than ACAD: AURA (18.1M) vs ACAD (56.3M). ACAD has higher revenues than AURA: ACAD (1.02B) vs AURA (0).
ACADAURAACAD / AURA
Capitalization4.39B389M1,127%
EBITDA104M-107.51M-97%
Gain YTD41.635-23.844-175%
P/E Ratio19.72N/A-
Revenue1.02B0-
Total Cash762M177M431%
Total Debt56.3M18.1M311%
FUNDAMENTALS RATINGS
ACAD: Fundamental Ratings
ACAD
OUTLOOK RATING
1..100
78
VALUATION
overvalued / fair valued / undervalued
1..100
62
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
29
PRICE GROWTH RATING
1..100
40
P/E GROWTH RATING
1..100
99
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ACADAURA
RSI
ODDS (%)
Bearish Trend 2 days ago
64%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
66%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 4 days ago
74%
Bullish Trend 9 days ago
78%
Declines
ODDS (%)
Bearish Trend 2 days ago
69%
Bearish Trend 2 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
64%
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ACAD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
AURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VDSIX24.96N/A
N/A
Victory Diversified Stock I
JISGX22.59N/A
N/A
JPMorgan Small Cap Growth L
RTSGX6.16N/A
N/A
Transamerica Small Cap Growth R6
JUEQX27.40N/A
N/A
JPMorgan US Equity R4
DVSMX23.86N/A
N/A
Driehaus Small Cap Growth Investor

ACAD and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACAD has been loosely correlated with AURA. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if ACAD jumps, then AURA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACAD
1D Price
Change %
ACAD100%
-0.91%
AURA - ACAD
42%
Loosely correlated
-2.64%
SYRE - ACAD
41%
Loosely correlated
-1.38%
STTK - ACAD
39%
Loosely correlated
-1.22%
CRSP - ACAD
39%
Loosely correlated
-2.30%
TECH - ACAD
39%
Loosely correlated
+0.55%
More

AURA and

Correlation & Price change

A.I.dvisor indicates that over the last year, AURA has been loosely correlated with VRDN. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if AURA jumps, then VRDN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AURA
1D Price
Change %
AURA100%
-2.64%
VRDN - AURA
52%
Loosely correlated
-0.33%
IDYA - AURA
50%
Loosely correlated
-1.52%
BEAM - AURA
47%
Loosely correlated
-2.91%
DSGN - AURA
47%
Loosely correlated
-1.95%
MGTX - AURA
47%
Loosely correlated
-2.54%
More